2024-01-08 12:34:45 ET
DENVER, Colo., Jan. 8, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Aclarion Inc (NASDAQ: ACON), Spectaire Holdings Inc (NASDAQ: SPEC), Cellectar Biosciences Inc (NASDAQ: CLRB), Ardelyx (NASDAQ: ARDX), BioCryst Pharma (NASDAQ: BCRX)and Sidus Space (NASDAQ: SIDU).
News
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan- Aclarion (NASDAQ: ACON) is trading at $3.9301, up $0.8701 (+28.43%), on 23.2M shares traded.
Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia- Cellectar Biosciences (NASDAQ: CLRB) is trading at $3.40, up $0.69 (+25.46%), on 26.3M shares traded.
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities- Ardelyx …
The post 24/7 Market News Lunch Break 8 Jan 2024 appeared first on 24/7 Market News .
For further details see:
24/7 Market News Lunch Break 8 Jan 2024